EUVIMEDEUVIMED entdecken
Crossref

Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation

Guanwenqing He, Ke Wan, Toshio Shimokawa, Kazushi Maruo

Statistics in Medicine · 2026

DOI: 10.1002/sim.70370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2026. Verfasst von Guanwenqing He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Data-Science, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan. Hauptthemen laut MEDLINE: Models, Statistical. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, clinical data obtained from patient surveys and medical records have become increasingly pivotal in medical data science. These clinical data, collectively referred to as “real‐world data (RWD),” are anticipated to play a key role in observational studies of specific diseases and in advancing personalized or precision medicine by identifying effective treatments for particular patient subgroups. Consequently, the estimation of heterogeneous treatment effects (HTEs) using RWD has garnered substantial attention. HTE estimation meaningfully contributes to precision medicine by enabling clinicians to make informed treatment decisions tailored to individual patient characteristics. Various treatment effect models for observational studies highlight the robust performance of bagging causal multivariate adaptive regression splines (MARS) (BCM). However, despite the notable efficacy of BCM, there remains potential for refinement. Here, we introduce a novel treatment effect model, the shrinkage causal bootstrap MARS method, which builds upon the following framework: initially, basis functions are estimated using transformed outcome bootstrap sampling MARS, followed by optimization of the model and parameter estimation via the group least absolute shrinkage and selection operator (LASSO) method. Our simulations demonstrate that the proposed method achieves improved mean square error and bias across most scenarios. Additionally, we validate the practical applicability of the method by implementing it on the ACTG 175 dataset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalHumansTreatment Effect HeterogeneityComputer SimulationPrecision MedicineRegression AnalysisMultivariate AnalysisObservational Studies as Topic

Stichwörter der Autor:innen

precision medicinereal‐world data (RWD)treatment effect models

Autor:innen und Institutionen

  • Department of Medical Data-Science, Graduate School of Medicine, Wakayama Medical University, Wakayama, Japan.
  • Clinical Study Support Center, Wakyama Medical University Hospital, Wakayama, Japan.
  • Department of Biostatistics, Faculty of Medicine, Wakayama Medical University, Wakayama, Japan.
  • Department of Biostatistics, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.

Zitieren

APA

He, G., Wan, K., Shimokawa, T., & Maruo, K. (2026). Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation. Statistics in Medicine. https://doi.org/10.1002/sim.70370

Vancouver

He G, Wan K, Shimokawa T, Maruo K. Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation. Statistics in Medicine. 2026. doi:10.1002/sim.70370

BibTeX
@article{He2026,
  author = {He, Guanwenqing and Wan, Ke and Shimokawa, Toshio and Maruo, Kazushi},
  title = {Extension of Bootstrap MARS With Group LASSO for Heterogeneous Treatment Effect Estimation},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70370}
}
Kostenlos starten →